Marilena Vrana/LinkedIn
Oct 5, 2025, 11:50
Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“Europe’s plasma supply chain is at a critical juncture, and current policies are not equipped to fix it.
In my latest opinion piece The Brussels Times, I break down why plasma-derived medicines require a holistic policy approach – especially as the Critical Medicines Act takes shape.
- Europe’s dependence on US plasma
- Why PDMPs don’t fit policies designed to tackle supply chains of chemically synthesized pharmaceuticals
- The pitfalls of “one-size-fits-all” approach
- The importance of collaboration
If we, Europeans, aim to achieve strategic autonomy and security of medicines supply, our policies must be grounded in reality.
International Plasma Awareness Week, which starts on October 6th, offers the perfect moment to reset Europe’s approach.”

Read more here.
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 14:04Breast Imaging Insights From Madrid – Swiss Journal of Radiology and Nuclear Medicine
-
Oct 6, 2026, 13:10Vinicius Fornazari: New Perspectives In Interventional Radiology From SOBRICE
-
Oct 6, 2026, 12:39Sarah Garvey: Putting The Patient Experience At The Heart Of VTE Care
-
Oct 6, 2026, 12:33Platelets Without Donors: Can Freeze-Dried Artificial Platelets Transform Trauma Care?
-
Oct 6, 2026, 12:03Louise St. Germain Bannon: Supporting the World Thrombosis Day
-
Oct 6, 2026, 11:39Joining the Hemophilia and Bleeding Disorders Community at the EHC 2026 – WFH
-
Oct 6, 2026, 10:56Moustafa Abdou: LE Cells and the Early Diagnosis of Lupus
-
Oct 6, 2026, 10:35Caitlin Raymond: Understanding IgA Deficiency and Anaphylaxis Risk
-
Oct 6, 2026, 10:15Zeeshan Ali Baig: AI-Designed Peptide for Rare Bleeding Disorder